• Wed. Apr 8th, 2026

23andMe sells gene-testing business to DNA drug maker Regeneron

By

May 19, 2025

Bankrupt genetic-testing firm 23andMe agreed to sell its data bank, which once contained DNA samples from about 15 million people, to the drug developer Regeneron Pharmaceuticals for $256 million.

Leave a Reply

Your email address will not be published. Required fields are marked *

Generated by Feedzy